Miriam Leanne Ward

Ms. Miriam Leanne Ward

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2016 in Infection, Genetics and Evolution
Verified
Journal Article
Closed access
MWMiriam Leanne Ward
Miriam Leanne Ward
SRSlavica Mijatovic Rustempasic
Slavica Mijatovic Rustempasic
SRSunando Roy
Sunando Roy
KRKunchala Rungsrisuriyachai
Kunchala Rungsrisuriyachai
JBJulie A. Boom
Julie A. Boom
MBMichael D Bowen
Michael D Bowen

15 August 2022 in Viruses
Verified
Journal Article
Open access
PDF file
SRSlavica Mijatovic Rustempasic
Slavica Mijatovic Rustempasic
JJJose Jaimes
Jose Jaimes
CPCharity Perkins
Charity Perkins
MWMiriam Leanne Ward
Miriam Leanne Ward
MEMathew Esona
Mathew Esona
MBMichael D Bowen
Michael D Bowen
Before the introduction of vaccines, group A rotaviruses (RVA) were the leading cause of acute gastroenteritis in children worldwide. The National Rotavirus Strain Surveillance System (NRSSS) was established in 1996 by the Centers for Disease Control and Prevention (CDC) to perform passive RVA surveillance in the USA. We report the distribution of RVA genotypes collected through NRSSS during the 2009–2016 RVA seasons and retrospectively examine the genotypes detected through the NRSSS since 1996. During the 2009–2016 RVA seasons, 2134 RVA-positive fecal specimens were sent to the CDC for analysis of the VP7 and VP4 genes by RT-PCR genotyping assays and sequencing. During 2009–2011, RVA genotype G3P[8] dominated, while G12P[8] was the dominant genotype during 2012–2016. Vaccine strains were detected in 1.7% of specimens and uncommon/unusual strains, including equine-like G3P[8] strains, were found in 1.9%. Phylogenetic analyses showed limited VP7 and VP4 sequence variation within the common genotypes with 1–3 alleles/lineages identified per genotype. A review of 20 years of NRSSS surveillance showed two changes in genotype dominance, from G1P[8] to G3P[8] and then G3P[8] to G12P[8]. A better understanding of the long-term effects of vaccine use on epidemiological and evolutionary dynamics of circulating RVA strains requires continued surveillance.